Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
This right is guaranteed under the Affordable Care Act's external review provisions [14]
For type 2 diabetes, the SURPASS trials demonstrated robust HbA1c reductions of 1.9-2.4 percentage points
When Wegovy is used alongside insulin or sulphonylureas, dose adjustments of these medications may be necessary to reduce the risk of hypoglycaemia, which in severe cases can precipitate seizures
The dose increases to 1.2 mg in week two, then 1.8 mg in week three, 2.4 mg in week four, and finally reaches the maintenance dose of 3.0 mg daily from week five onward
This dual benefit is particularly appealing for patients who are managing both diabetes and obesity, as it addresses two critical health issues simultaneously
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
